Feasibility of dose reduction for [18F]FDG-PET/MR imaging of patients with non-lesional epilepsy

被引:1
|
作者
Kertesz, Hunor [1 ,5 ]
Traub-Weidinger, Tatjana [2 ]
Cal-Gonzalez, Jacobo [3 ]
Rausch, Ivo [1 ]
Muzik, Otto [4 ]
Sundar, Lalith Kumar Shyiam [1 ]
Beyer, Thomas [1 ]
机构
[1] Med Univ Vienna, Ctr Med Phys & Biomed Engn, QIMP Team, Vienna, Austria
[2] Med Univ Vienna, Dept Biomed Imaging & Image guided Therapy, Div Nucl Med, Vienna, Austria
[3] Protontherapy Ctr Quironsalud, Ion Beam Applicat, Madrid, Spain
[4] Wayne State Univ, Childrens Hosp Michigan, Detroit Med Ctr, Sch Med,Dept Radiol, Detroit, MI USA
[5] Med Univ Vienna, Ctr Med Phys & Biomed Engn, QIMP Team, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2023年 / 62卷 / 03期
关键词
fluorodeoxyglucose; F18; positron emission tomography; image reconstruction; brain; F-18-FDG PET; RECONSTRUCTION; QUANTIFICATION; PET/MRI; BRAIN;
D O I
10.1055/a-2015-7785
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of the study was to evaluate the effect of reduced injected [18F]FDG activity levels on the quantitative and diagnostic accuracy of PET images of patients with non-lesional epilepsy (NLE).Nine healthy volunteers and nine patients with NLE underwent 60-min dynamic list-mode (LM) scans on a fully-integrated PET/MRI system. Injected FDG activity levels were reduced virtually by randomly removing counts from the last 10-min of the LM data, so as to simulate the following activity levels: 50 %, 35 %, 20 %, and 10 % of the original activity. Four image reconstructions were evaluated: standard OSEM, OSEM with resolution recovery (PSF), the A-MAP, and the Asymmetrical Bowsher (AsymBowsher) algorithms. For the A-MAP algorithms, two weights were selected (low and high). Image contrast and noise levels were evaluated for all subjects while the lesion-to-background ratio (L/B) was only evaluated for patients. Patient images were scored by a Nuclear Medicine physician on a 5-point scale to assess clinical impression associated with the various reconstruction algorithms.The image contrast and L/B ratio characterizing all four reconstruction algorithms were similar, except for reconstructions based on only 10 % of total counts. Based on clinical impression, images with diagnostic quality can be achieved with as low as 35 % of the standard injected activity. The selection of algorithms utilizing an anatomical prior did not provide a significant advantage for clinical readings, despite a small improvement in L/B (< 5 %) using the A-MAP and AsymBowsher reconstruction algorithms.In patients with NLE who are undergoing [18F]FDG-PET/MR imaging, the injected [18F]FDG activity can be reduced to 35 % of the original dose levels without compromising.
引用
收藏
页码:200 / 213
页数:14
相关论文
共 50 条
  • [1] Evaluation of reducing the [18F]FDG activity levels for clinical readings of PET/MRI scans of patients with non-lesional epilepsy
    Kertesz, H.
    Traub-Weidinger, T.
    Cal-Gonzalez, J.
    Rausch, I.
    Muzik, O.
    Sundar, L. Shiyam
    Beyer, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S382 - S382
  • [2] Validation of FDG-PET/MRI coregistration in non-lesional refractory childhood epilepsy
    Rubi Sureda, S.
    Setoain, X.
    Donaire, A.
    Bargallo, N.
    Falcon, C.
    Calvo, A.
    Sola, O.
    Aparicio, J.
    Campistol, J.
    Pons, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S218 - S218
  • [3] COMPARATIVE VALUE OF SISCOM, FDG-PET AND INTRACRANIAL EEG IN PATIENTS WITH NON-LESIONAL EXTRATEMPORAL EPILEPSY
    Kudr, M.
    Krsek, P.
    Jahodova, A.
    Rybar, J.
    Trnka, J.
    Jaruskova, M.
    Michalova, K.
    Sanda, J.
    Kyncl, M.
    Zamecnik, J.
    Tichy, M.
    Komarek, V.
    EPILEPSIA, 2012, 53 : 63 - 64
  • [4] Cinematic rendering of [18F]FDG-PET/MR
    Huellner, Martin W.
    Engel, Klaus
    Morand, Gregoire B.
    Stadlinger, Bernd
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (12) : 3805 - 3806
  • [5] Utility of Absolute Quantification in Non-lesional Extratemporal Lobe Epilepsy Using FDG PET/MR Imaging
    Traub-Weidinger, Tatjana
    Muzik, Otto
    Sundar, Lalith Kumar Shiyam
    Aull-Watschinger, Susanne
    Beyer, Thomas
    Hacker, Marcus
    Hahn, Andreas
    Kasprian, Gregor
    Klebermass, Eva-Maria
    Lanzenberger, Rupert
    Mitterhauser, Markus
    Pilz, Magdalena
    Rausch, Ivo
    Rischka, Lucas
    Wadsak, Wolfgang
    Pataraia, Ekaterina
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [6] Indication for F-18-FDG or flumazenil PET in presurgical evaluation of patients with non-lesional temporal lobe epilepsy
    Debets, RMC
    Comans, EFI
    Velis, DN
    Boas, WV
    Veltman, DJ
    Lammertsma, AA
    EPILEPSIA, 2004, 45 : 181 - 181
  • [7] 18F FDG-PET imaging in musculoskeletal infection
    Stumpe, K. D. M.
    Strobel, K.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (02): : 131 - 142
  • [8] Quality assurance of [18F]FDG-PET/CT scans after reduction of the FDG dose
    Laugesen, S.
    Lorentzen, S. S.
    Buch-Olsen, K. M.
    Jakobsen, N. M.
    Nadaraja, S.
    Nygaard, S. T.
    Thilsing-Hansen, K.
    Pedersen, C. G.
    Behzad, M. N.
    Gerke, O.
    Hildebrandt, M. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S313 - S313
  • [9] Low-dose PET/MRI of patients with non-lesional epilepsy
    Cal-Gonzalez, J.
    Schramm, G.
    Vunckx, K.
    Rausch, I.
    Sundar, L. Shiyam
    Nuyts, J.
    Iraub-Weidinger, I.
    Beyer, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S611 - S612
  • [10] SISCOM and FDG-PET in patients with non-lesional extratemporal epilepsy: correlation with intracranial EEG, histology, and seizure outcome
    Kudr, Martin
    Krsek, Pavel
    Marusic, Petr
    Tomasek, Martin
    Trnka, Jiri
    Michalova, Katerina
    Jaruskova, Monika
    Sanda, Jan
    Kyncl, Martin
    Zamecnik, Josef
    Rybar, Jan
    Jahodova, Alena
    Mohapl, Milan
    Komarek, Vladimir
    Tichy, Michal
    EPILEPTIC DISORDERS, 2013, 15 (01) : 3 - 13